SLC2A4 Polymorphisms Can Be a New Molecular Biomarker for Sports Genomics

Authors

  • Canan Sercan Marmara University, Faculty of Medical Biology and Genetics, Department of Medical biology and Genetics, Istanbul, Turkey
  • Fatma Akpunar Marmara University, Faculty of Medical Biology and Genetics, Department of Medical biology and Genetics, Istanbul, Turkey
  • Kadir Sinan Arslan Üsküdar University, Faculty of Engineering and Natural Sciences, Department of Molecular Biology and Genetics, Istanbul, Turkey
  • Korkut Ulucan Marmara University, Faculty of Medical Biology and Genetics, Department of Medical biology and Genetics, Istanbul, Turkey
  • Sezgin Kapıcı Üsküdar University, Faculty of Engineering and Natural Sciences, Department of Molecular Biology and Genetics, Istanbul, Turkey
Abstract:

"SLC2A4 Polymorphisms Can Be a New Molecular Biomarker for Sports Genomics" is an "Editorial Article" and hasn't abstract.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

Can Neurogulin 1 be an Important Biomarker for Creativity in Sports?

As this is an editorial, don't need the abstract.

full text

Can Prostate Specific Antigen Be Used as New Biomarker for Early Diagnosis of Breast Cancer?

Introduction: As a glycoprotein, Plasma Prostate-Specific Antigen (PSA) is mainly produced by prostate epithelial cells and is used as a major diagnostic tool for prostate cancer. A group of researchers relate the elevated number of estrogen receptors in breast cancer samples to the over-production of PSA in this type of cancer. Therefore, the present study aimed to determine the participants' ...

full text

can neurogulin 1 be an important biomarker for creativity in sports?

as this is an editorial, don't need the abstract.

full text

Ribonucleotide Reductase Subunit M2 Can Be New Molecular Target and Prognostic Biomarker of Hepatocellular Carcinoma

After approval of imatinib for treatment of chronic myeloid leukemia, molecular-targeted therapies make change of the management strategies against cancers. Many target molecules have been revealed in several cancers such as lung cancer, breast cancer, colorectal cancer, and hematopoietic tumor. Representative molecular-targeted agents are trastuzumab for breast cancer, imatinib and rituximab f...

full text

Personal genomics: information can be harmful.

Information is generally considered a good thing. Information may of course lead to benefit through some action based on information. But, action can also lead to harm. We know about harm not only from everyday experience and common sense but also from the field of clinical medicine. Approaches to weigh harm vs. benefit have been developed in clinical medicine to aid doctors, patients and polic...

full text

a new approach to credibility premium for zero-inflated poisson models for panel data

هدف اصلی از این تحقیق به دست آوردن و مقایسه حق بیمه باورمندی در مدل های شمارشی گزارش نشده برای داده های طولی می باشد. در این تحقیق حق بیمه های پبش گویی بر اساس توابع ضرر مربع خطا و نمایی محاسبه شده و با هم مقایسه می شود. تمایل به گرفتن پاداش و جایزه یکی از دلایل مهم برای گزارش ندادن تصادفات می باشد و افراد برای استفاده از تخفیف اغلب از گزارش تصادفات با هزینه پائین خودداری می کنند، در این تحقیق ...

15 صفحه اول

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 5  issue None

pages  1- 3

publication date 2017-10

{@ msg @}

By following a journal you will be notified via email when a new issue of this journal is published.

Keywords

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023